Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thoracic malignancies associated with AIDS.

K Katariya1, R J Thurer

  • 1Division of Cardiothoracic Surgery, University of Miami School of Medicine, FL 33101, USA.

Seminars in Thoracic and Cardiovascular Surgery
|May 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduction of postoperative hypothermia with a new warming device: a prospective randomized study in off-pump coronary artery surgery.

The Journal of cardiovascular surgery·2009
Same author

Sirolimus and tacrolimus in clinical cardiac transplantation.

Transplantation proceedings·2002
Same author

Cryotherapy in early lung cancer.

Chest·2001
Same author

Oral amiodarone reduces incidence of postoperative atrial fibrillation.

The Annals of thoracic surgery·1999
Same author

Malignancies associated with the immunocompromised state.

Chest surgery clinics of North America·1999
Same author

Surgical management of empyema.

Clinics in chest medicine·1998
Same journal

A Systematic Review on the Impact of Postoperative Rehabilitation Programs in Thoracic Surgery Patients.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Endoscopic vs. Operative Management of Acute Esophageal Perforation: A 21-Year Experience at a High-Volume Referral Center.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Valved Sano Conduit During the Norwood Procedure: A Contemporary Review of Early Outcomes, Reintervention Burden, and Pulmonary Artery Growth.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Propensity Score-Matched Analysis Comparing Modified Konno Procedure and Transaortic Septal Myectomy in Children With Left Ventricular Outflow Tract Obstruction.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Post-Operative Hemothorax: Uniportal Video-Assisted Thoracic Surgery vs Thoracotomy-Analysis of Outcomes and Costs.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Palliative Care Throughout the Entire Perioperative Pathway in Cardiovascular Surgery.

Seminars in thoracic and cardiovascular surgery·2026
See all related articles

Individuals with HIV and AIDS have a higher risk of aggressive cancers like Kaposi

Area of Science:

  • Oncology
  • Immunology
  • Infectious Diseases

Background:

  • Immunocompromised individuals face increased risks for malignant tumors.
  • Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) significantly contribute to the immunocompromised population.
  • Certain cancers are recognized as AIDS-defining illnesses.

Purpose of the Study:

  • To highlight the increased incidence and aggressive nature of cancers in patients with HIV/AIDS.
  • To underscore the importance of aggressive cancer therapy in this patient group.

Main Methods:

  • Review of existing literature on cancer incidence in HIV/AIDS patients.
  • Analysis of cancer aggressiveness and prognosis in immunocompromised individuals.
  • Evaluation of current treatment strategies and their impact on survival.

Related Experiment Videos

Main Results:

  • Kaposi's sarcoma, non-Hodgkin's lymphoma, primary CNS lymphoma, and invasive cervical carcinoma are AIDS-defining.
  • Lung cancer occurs with higher frequency in AIDS patients.
  • Malignant tumors in this population are generally more aggressive with poorer prognoses.

Conclusions:

  • HIV/AIDS patients exhibit a higher risk of developing aggressive cancers.
  • Despite poor prognosis, aggressive cancer treatment is warranted due to improved survival rates with modern therapies.